Apply Now

Maximizing Your Success in Multi-Parametric Flow Cytometry Series - 2/2

Hybrid 2-part series designed to take you through maximizing your flow cytometer.

Join Thermo Fisher's flow cytometry expert for this hybrid 2-part series Lunch & Learn to gain fundamental technical and educational skills. You will be introduced to flow cytometry research applications and techniques.

Part 1's recording can be found here.

March 3 - Part 2

Enabling Single Cell Analysis with Flow Cytometry

Flow cytometry provides many advantages including single-cell quantitative analysis within heterogenous populations, high sample throughput, and multiplex cell characterization, particularly in non-adherent cell models. Discussion will include a variety of probes and assays for immunophenotyping, viability, and proliferation. These technologies and methods will underscore scalable and streamlined flow cytometric analyses in a variety of cell-based models.

Location

The in-person event will take place at:

University Lab Partners, 5270 California Ave, Suite 300, Irvine, CA 92617.

Special Offer

For a limited time, Thermo Fisher is extending a special offer for researchers on their Invitrogen™ flow cytometry products. Attend both sessions of the upcoming webinar series in-person, and get entered into a raffle to receive test size flow cytometry antibodies (25-50 µg/tests*) for the initial panel. All other attendees will receive a special quote and assistance with their first panel. More details on the offer here.

 

Event Speakers

Chris langsdorf headshot

Chris Langsdorf

Staff Scientist, Research & Development
Thermo Fisher Scientific

As a Staff Scientist at Thermo Fisher Scientific, Chris leads a cross-functional team developing fluorescent probes, labeling technologies, and cell-based assays focused on immunotherapy research. Over the last fourteen years, he has developed more than seventy novel reagents for characterizing disease on a cellular level in areas such as innate and adaptive immunity, cell growth and proliferation, apoptosis and cytotoxicity, and endocytosis. Currently he is focused on improving the development of cell therapies and therapeutic antibodies.

Mike.Hernandez_head shot

Mike Hernandez, PhD

Technical Sales Specialist
Thermo Fisher Scientific

Mike Hernandez received his PhD from the University of California – Irvine, under the mentorship of Dr. Andrea Tenner. His work investigated the contribution of C5a receptor 1 (C5aR1) to neuroinflammation and neuronal dysfunction in Alzheimer’s Disease, using vitro cell culture studies and mouse models of the disease. Prior to his current role as Technical Sales Specialist for flow cytometry antibodies and reagents, he supported the same portfolio in two different roles: Technical Applications Scientist and Associate Product Manager.

Event Partners

thermo fisher scientfic logo
 

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.

Event Details

Thursday, March 3, 2022

12:00 PM - 01:00 PM

Hybrid 2-part Lunch & Learn

Register Now

Upcoming Event

May 26, 2022
05:00 PM - 07:30 PM

OC LIFe (Lifesciences Innovators Forum) ft. Haleh Armian

Register Now

Apply for residency today

Do you have a great company in the bioscience or medtech industry? Do you need wet-lab and/or fabrication space to develop and test your product?

Apply

Other Events

May 19, 2022
12:00 PM - 01:00 PM

Using Pluripotent Stem Cells to Guide Your Discoveries

Register Now
May 26, 2022
01:00 PM - 02:00 PM

Clinical Trials Series 4/6: Informed Consent (Medical Devices)

Register Now
June 9, 2022
01:00 PM - 02:00 PM

Clinical Trials Series 5/6: Creating a Study Protocol and Consent

Register Now